OncoCellMDx is a company dedicated to the development and commercialization of novel diagnostic tests using proprietary technologies. In particular, it utilizes noninvasive blood-based immunogenomic assays that help physicians to better understand the underlying pathology. Its product helps to assess the severity of prostate cancer.